Senator FARRELL (South Australia—Minister for Trade and Tourism, Special Minister of State and Deputy Leader of the Government in the Senate) (14:05): I think I indicated when I was asked this question last week that, being a diabetic myself, I do have some familiarity with the drugs that are on the PBS, and of course the drug that you've just mentioned, Fiasp, is a fast acting insulin drug for diabetes—a very important drug. Minister Butler's office was made aware on 22 February 2023— The PRESIDENT: Minister Farrell, please resume your seat. Senator Ruston? Senator Ruston: A point of order on relevance again—the question was very specific about the agreement of this chamber for the medicine to be permanently, ongoingly listed. I'm just asking the minister, through you, President, if he could please advise when the 15,000 people who rely on this drug are going to be advised of the decision by this government to actually permanently list it. The PRESIDENT: Thank you, Senator Ruston. I believe the minister is being relevant, and I will listen to the remainder of his answer. Senator FARRELL: I don't know why the opposition keeps asking me questions and then stops me from answering them, but let's see how we go. Minister Butler's office was made aware on 22 February 2023 of Novo Nordisk's intention to delist the drug from the PBS on 1 April 2023. The government appreciates the distress that a delisting— (Time expired) The PRESIDENT: Senator Ruston, a second supplementary?